YouTube2Text

tutorial on diabetes part 3 t5 — Transcript

by PharmacoPhoto · 4,469 words · 744 segments · language en · Watch on YouTube

Full transcript

  1. 0:03Okay, so now we have one last portion of
  2. 0:06the tutorial, which is the comparison of
  3. 0:08two drugs, the sulfonylureas
  4. 0:11and the biguanides.
  5. 0:13Just to precede the comparison though, I
  6. 0:16need to explain the fact that these two
  7. 0:19drugs are made for different types of
  8. 0:22diabetics.
  9. 0:24One of these drugs,
  10. 0:25the sulfonylureas,
  11. 0:27the way they primarily act is to
  12. 0:30increase insulin.
  13. 0:33And it would not be the kind of drug
  14. 0:36that you would, for instance, give to a
  15. 0:38woman with PCOS, polycystic ovarian
  16. 0:41syndrome or polycystic ovarian disease,
  17. 0:44uh or in, for instance, a person who has
  18. 0:46a problem controlling weight or even in
  19. 0:49the first stages of uh diabetes. The
  20. 0:53insulin is a part of that spiral of
  21. 0:55events that perpetuates, for instance,
  22. 0:58insulin insensitivity. It
  23. 1:01it perpetuates polycystic ovarian
  24. 1:04syndrome.
  25. 1:05So that is a medication
  26. 1:08that increases endogenous insulin and
  27. 1:12it's definitely not that first line
  28. 1:15therapy for people in early stages
  29. 1:18diabetes.
  30. 1:20But it is going to be helpful in, for
  31. 1:23instance, a later stage diabetes because
  32. 1:26in later stage diabetes, the pancreas of
  33. 1:29the client actually starts to put out
  34. 1:32less insulin.
  35. 1:34You you think about it. Uh
  36. 1:36a diabetic has been putting out a lot of
  37. 1:38insulin for a really long time
  38. 1:41and then eventually, very simplistically
  39. 1:44speaking, I mean it's not technically
  40. 1:45correct, but simplistically speaking,
  41. 1:48the pancreas burns out.
  42. 1:50Uh the other drug, metformin, increases
  43. 1:53insulin sensitivity.
  44. 1:56And it actually treats polycystic
  45. 1:59ovarian
  46. 2:01and it's very helpful in pretty much all
  47. 2:04stages of diabetes.
  48. 2:07So just get that picture in your mind
  49. 2:10that you're not just talking about two
  50. 2:13drugs that treat the exact same person.
  51. 2:17It's two drugs that treat the same
  52. 2:18disease, but they're very different
  53. 2:21drugs.
  54. 2:23And with that, we can begin to discuss
  55. 2:26the second sub question in this multi
  56. 2:28part tutorial question. And that is
  57. 2:31discuss gliclazide with respect to its
  58. 2:35suitability in the early stages of type
  59. 2:38two diabetes.
  60. 2:40And a note on that, you need to discuss
  61. 2:43gliclazide and not gliclazide modified
  62. 2:47release.
  63. 2:48So the normal gliclazide is the one
  64. 2:51you'll be discussing, and that's
  65. 2:53released immediately. So some of the
  66. 2:56newer articles out there will be
  67. 2:59discussing the modified released
  68. 3:02gliclazide. You will be discussing the
  69. 3:05normal gliclazide.
  70. 3:08And one of the first things that we need
  71. 3:10to know in order to understand
  72. 3:11gliclazide, or for that matter any of
  73. 3:13our drugs, is to understand its main
  74. 3:15mechanisms of action. Gliclazide is a
  75. 3:18sulfonylurea,
  76. 3:20and that drug class works by increasing
  77. 3:24the amount of insulin released from the
  78. 3:27pancreas.
  79. 3:29Now just knowing that, we can predict a
  80. 3:32number of things about that medication
  81. 3:34which are important to discuss in your
  82. 3:36answer to the question.
  83. 3:38The first is when the drug is
  84. 3:40appropriate in the progression of type
  85. 3:42two diabetes.
  86. 3:44In this graph,
  87. 3:46you see what normally happens in people
  88. 3:48who have pre diabetes, the first stages
  89. 3:51of diabetes, and the middle stages of
  90. 3:54diabetes. And as a matter of fact, in
  91. 3:56the latter stages of type two diabetes,
  92. 3:59the beta cell function, this line over
  93. 4:02here actually continues to decrease
  94. 4:05significantly to the point where there's
  95. 4:07often times little production of insulin
  96. 4:10in the long-standing diabetic, the type
  97. 4:13two diabetic.
  98. 4:15Notice this huge increase in insulin
  99. 4:18release in those early stages, the
  100. 4:20prediabetic stages. Indeed, as we have
  101. 4:23seen in this tutorial, that
  102. 4:25hyperinsulinemia
  103. 4:27during that time is responsible for
  104. 4:30quite a few of the manifestations.
  105. 4:32So let's just think about it.
  106. 4:35Would you predict that a medication that
  107. 4:37increases insulin release from the
  108. 4:39pancreas is going to be a preferred
  109. 4:42medication in the early stages of type
  110. 4:45two diabetes?
  111. 4:47No, the sulfonylureas are ideally placed
  112. 4:50in these latter stages of type two
  113. 4:52diabetes where the beta cells of the
  114. 4:55pancreas, simplistically put, start to
  115. 4:57fatigue.
  116. 4:59It's often times also used in the middle
  117. 5:01portion of diabetes where the normal
  118. 5:04production of insulin is kind of still
  119. 5:07maintained, but it's used in combination
  120. 5:10with, for instance, metformin that
  121. 5:12increases the sensitivity of the cells
  122. 5:14of the skeletal muscle and and so forth,
  123. 5:17those cells
  124. 5:18to use the endogenous insulin. So in
  125. 5:21that setting, the diabetic's glucose
  126. 5:24levels are not going to be maintained
  127. 5:26just by the one single drug.
  128. 5:29Knowing the action of that drug also
  129. 5:33allows us to predict some of the side
  130. 5:35effects of the drug as well.
  131. 5:37Gliclazide basically increases insulin
  132. 5:40release at the level of the pancreas.
  133. 5:42And remember what insulin does. This
  134. 5:45slide should refresh your memory on
  135. 5:46that. It increases
  136. 5:49fat synthesis, forcing adipocytes or fat
  137. 5:53cells to make triacylglycerols.
  138. 5:56It decreases lipolysis,
  139. 5:58and both of those actions
  140. 6:01of insulin will be resulting in an
  141. 6:04increase in weight gain.
  142. 6:07And then the high levels of insulin
  143. 6:09stimulate testosterone release from the
  144. 6:11female ovaries as well, contributing to
  145. 6:14the development and progression of
  146. 6:16polycystic ovarian syndrome.
  147. 6:20But what do you think the main side
  148. 6:22effect would be? The one that is
  149. 6:24actually life-threatening, maybe not as
  150. 6:26common as other ones, but the one that's
  151. 6:28really life-threatening.
  152. 6:30It would involve those increased levels
  153. 6:33of insulin, which is a hypoglycemic
  154. 6:37hormone.
  155. 6:38And what does, you know, what happens
  156. 6:40when we have high levels of a
  157. 6:42hypoglycemic
  158. 6:44hormone?
  159. 6:46What's the potential here?
  160. 6:48Yeah, yeah, hypoglycemia.
  161. 6:50Yes, there is an increase for every one
  162. 6:53of the sulfonylureas to develop
  163. 6:55hypoglycemia when you take that drug.
  164. 6:59That is the main number one side effect
  165. 7:01of all sulfonylureas. They all have a
  166. 7:04different kind of risk of developing
  167. 7:07hypoglycemia, and glipizide is one of
  168. 7:10the better ones. So it the likelihood of
  169. 7:14hypoglycemia isn't as high as, for
  170. 7:17instance,
  171. 7:18some of the other ones. But
  172. 7:21but it is still there, and therefore
  173. 7:24we're going to have to make sure to, you
  174. 7:26know, talk to the client about the risks
  175. 7:29of developing hypoglycemia.
  176. 7:32And just a note right here, when you
  177. 7:34hear that a number of drugs are termed
  178. 7:37oral hypoglycemic
  179. 7:39agents,
  180. 7:41you're going to kind of wonder why do
  181. 7:43they call it a hypoglycemic agent when
  182. 7:45it doesn't actually cause hypoglycemia?
  183. 7:48There are some
  184. 7:50hypoglycemic agents that don't cause a
  185. 7:53profound hypoglycemia, or sometimes they
  186. 7:56don't cause hypoglycemia at all.
  187. 7:57Sometimes they're they should be
  188. 7:59actually termed euglycemic. So they
  189. 8:02normalize the glucose levels.
  190. 8:05But the thing is that uh a lot authors
  191. 8:07use the term
  192. 8:09uh like hypoglycemic agent for even
  193. 8:11metformin, which has almost no
  194. 8:13possibility of causing hypoglycemia,
  195. 8:15just simply because it's an accepted
  196. 8:17term. It it just kind of means that it
  197. 8:20is actually decreasing the levels of the
  198. 8:24uh glucose to for instance a normal
  199. 8:27level or in some cases uh uh a subnormal
  200. 8:30level. So hypoglycemia in that instance.
  201. 8:34So just remember that the term oral
  202. 8:35hypoglycemic agent doesn't actually mean
  203. 8:38that it's going to definitely cause
  204. 8:39hypoglycemia and uh that it is used kind
  205. 8:43of uh just as a generic term to mean
  206. 8:47that it is going to decrease the level
  207. 8:48of glucose in the system.
  208. 8:52So back to glyburide,
  209. 8:54uh one of the important things that
  210. 8:55we're going to have to do when a client
  211. 8:57is prescribed a hypoglycemic agent that
  212. 9:00can cause hypoglycemia, so glyburide um
  213. 9:04is to inform them about what
  214. 9:06hypoglycemia is because they the client
  215. 9:08may not actually know. You know, we've
  216. 9:10got to tell them how serious it is.
  217. 9:12We've got to give them an idea of what's
  218. 9:14going to happen in the first stages of
  219. 9:16hypoglycemia so that they can actually
  220. 9:18identify it and you know what to do in
  221. 9:20the case of them experience experiencing
  222. 9:23a hypo.
  223. 9:25So you don't just tell them a hundred
  224. 9:27different signs. You don't just give
  225. 9:28them all of these signs that are on this
  226. 9:31page for instance. They would just it
  227. 9:32would just blur and they wouldn't
  228. 9:34actually remember any of it. So what you
  229. 9:36need to do is just give them a little
  230. 9:38bit of a picture and just say something
  231. 9:40to the effect of you know if you're
  232. 9:42experiencing a rapid extreme hunger and
  233. 9:45mental confusion, you may be about to
  234. 9:47experience a hypoglycemic attack or you
  235. 9:49may be in the middle of one. So what you
  236. 9:51need to do at that time is to drink
  237. 9:53something that has glucose in it and
  238. 9:56also you know give them a bit more
  239. 9:58education about hypoglycemia. So they
  240. 10:01need to eat or drink something that has
  241. 10:03some glucose in it, preferably glucose.
  242. 10:06Um yeah so uh uh we we always need to be
  243. 10:10safe. And client education is oftentimes
  244. 10:14a part of that safety.
  245. 10:17And another disadvantage in using
  246. 10:19gliclazide during the early stages of
  247. 10:21diabetes is it ultimately it contributes
  248. 10:25to early fatigue of the client's beta
  249. 10:28cells. So the pancreatic beta cells,
  250. 10:30remember back to this graph over here.
  251. 10:32Let's take a look at this one right
  252. 10:33here.
  253. 10:34So that insulin production
  254. 10:37is up in the early stages of diabetes.
  255. 10:39What what and and that right there that
  256. 10:42you know profound increase in the
  257. 10:44production of insulin from the beta
  258. 10:46cells of the pancreas, that actually
  259. 10:48leads to this dip over here in the later
  260. 10:52stages.
  261. 10:54So you know what would happen if for
  262. 10:56instance we gave an agent that increased
  263. 10:59this insulin even more? Well we would
  264. 11:01fatigue those beta cells even quicker.
  265. 11:04So ultimately
  266. 11:06uh the administration of gliclazide for
  267. 11:10instance is going to potentially
  268. 11:13uh fatigue lead to an earlier fatigue of
  269. 11:16the beta cells in and um yeah that's
  270. 11:19another one of those disadvantages
  271. 11:21you'll want to cite as far as the
  272. 11:23reasons that it wouldn't be an ideal
  273. 11:26medication for early diabetics.
  274. 11:30Because after we burn out basically burn
  275. 11:33out it's kind of a simplistic way of
  276. 11:35looking at it. Uh it's a bit more uh
  277. 11:38complicated technically. But uh as we
  278. 11:41burn out the beta cells um you know a
  279. 11:44person is going to have to start
  280. 11:45injections of insulin.
  281. 11:48And we oftentimes think of people who
  282. 11:51are injecting insulin as a type one
  283. 11:53diabetic where there's you know no
  284. 11:55functional beta cells at all. But in
  285. 11:58late stage diabetes type two there
  286. 12:00oftentimes is a need to inject insulin
  287. 12:02in those individuals. And they that's
  288. 12:05not to say that they have type one
  289. 12:07diabetes then. They still have type two
  290. 12:10diabetes but they just have fatigued
  291. 12:12beta cells with their disorder.
  292. 12:15So, what I'd like you to do right now is
  293. 12:17attempt this one in your own words, and
  294. 12:20just give a few pointers
  295. 12:23on your worksheet. And um we'll be
  296. 12:27coming back to you in just a little bit.
  297. 12:29So, discuss gliclazide with respect to
  298. 12:31its suitability in the early stages of
  299. 12:34type two diabetes. And just remember,
  300. 12:36the important thing is you discuss it.
  301. 12:40Why would it be good if it if there's
  302. 12:42any advantages? And why is it going to
  303. 12:44be bad?
  304. 12:45And um you know, so do the advantages
  305. 12:49outweigh the disadvantages and so forth?
  306. 12:51So, this is a discussion, and I'll just
  307. 12:53come back to you in just a little bit.
  308. 13:00So, on reflection of that question,
  309. 13:02almost all of the things you discuss
  310. 13:05will be negative aspects of using
  311. 13:07gliclazide because it simply isn't a
  312. 13:10first-line therapy for early stage
  313. 13:12diabetes. It's it's way down. It's not
  314. 13:15anywhere close to
  315. 13:17a recommended medication in early stages
  316. 13:20of diabetes.
  317. 13:21You might say something to the effect
  318. 13:22of, you know, while gliclazide may give
  319. 13:25some additional glucose-lowering effects
  320. 13:28in early stage diabetes, the dangers and
  321. 13:31side effects greatly outweigh the
  322. 13:34positive benefits that would be uh
  323. 13:37gained from using gliclazide. And as
  324. 13:41such, gliclazide is not recommended in
  325. 13:43the early stages of diabetes type two.
  326. 13:46And then you could mention the main
  327. 13:48mechanism of action being to stimulate
  328. 13:50the
  329. 13:51the pancreatic beta cells to release
  330. 13:53more insulin regardless of the current
  331. 13:55levels of glucose or of insulin itself,
  332. 13:59which is not ideal in prediabetes or
  333. 14:02early stage type two diabetes because
  334. 14:04the pancreas is already producing normal
  335. 14:07or even high amounts of insulin.
  336. 14:10But don't just stop there. What you need
  337. 14:12to do is say that, you know, since
  338. 14:15there's virtually no benefit in
  339. 14:17prescribing the drug during that time,
  340. 14:19the practical risks are very important
  341. 14:22to understand.
  342. 14:23And
  343. 14:24that's the point at which you mention
  344. 14:26the fact that it can cause
  345. 14:27life-threatening hypoglycemia and that
  346. 14:30there's an increase in insulin that will
  347. 14:33lead to weight gain. And that weight
  348. 14:36gain and the increase of insulin is
  349. 14:38going to predispose a female, for
  350. 14:40instance, to polycystic ovarian
  351. 14:43syndrome.
  352. 14:44And and it's also going to contribute to
  353. 14:47beta cell decline over time.
  354. 14:51So
  355. 14:52hopefully from that you have a picture
  356. 14:54of the sulfonylureas and where they fit
  357. 14:56into the progression of type two
  358. 14:58diabetes. It's definitely not a
  359. 15:01first-line therapy for early-stage
  360. 15:03diabetes.
  361. 15:05It's more of a later-stage treatment for
  362. 15:08diabetes when the beta cells are not
  363. 15:10really putting out enough insulin of
  364. 15:13their own.
  365. 15:14And the alternative to that during that
  366. 15:16time is that the person injects some
  367. 15:18insulin, some exogenous insulin.
  368. 15:22And are there any other questions on
  369. 15:24that?
  370. 15:26Okay, so everybody thinks that they have
  371. 15:28the type of answer that's going to score
  372. 15:30well in that question.
  373. 15:33Okay, and so if we don't have any
  374. 15:35questions, then the last diabetes drug
  375. 15:38that we're going to be discussing is the
  376. 15:39biguanide called metformin. Metformin is
  377. 15:43the first-line therapy for diabetes type
  378. 15:46two. It's the first-line therapy for,
  379. 15:48for instance,
  380. 15:50insulin resistance all the way to
  381. 15:53later-stage diabetes. And although diet
  382. 15:56and exercise is still the number one
  383. 15:59therapy for diabetes and for insulin
  384. 16:02resistance, metformin is our best
  385. 16:04medication for diabetes.
  386. 16:07And what I just said kind of addresses
  387. 16:09another question that you may have
  388. 16:11because
  389. 16:12there's about 50% of this tutorial
  390. 16:14dedicated to insulin resistance and, you
  391. 16:17know, how we would actually you know the
  392. 16:19risk factors of insulin resistance and
  393. 16:21so forth. And you know why is it that
  394. 16:24it's so disproportional you know why
  395. 16:25isn't it that we've actually spent more
  396. 16:27time on the drugs for diabetes. Well the
  397. 16:31main reason is because of the fact that
  398. 16:33the efficacy of diet and lifestyle
  399. 16:36therapies is far greater than metformin
  400. 16:39or metformin combined with anything
  401. 16:41else. So really your number one goal for
  402. 16:44diabetics is diet and exercise therapy
  403. 16:47and then of course we'd need to know our
  404. 16:49drugs as well.
  405. 16:50So this sub question relevant to
  406. 16:53metformin is discuss metformin with
  407. 16:56respect to the mechanisms of action and
  408. 16:58the most important side effects. So all
  409. 17:00we're asking for is the mechanisms of
  410. 17:02action and the most important side
  411. 17:04effects and remember in pharmacology the
  412. 17:07most important side effects pertain to
  413. 17:09the ones that are probably rare but can
  414. 17:13you know cause extreme harm or even
  415. 17:15death and the ones that are frequently
  416. 17:18seen and are often times the reason that
  417. 17:21the person cannot tolerate the drug. So
  418. 17:23those are the two
  419. 17:25you know groups of really important side
  420. 17:27effects when I ask you about important
  421. 17:29side effects.
  422. 17:30And with respect to the mechanisms of
  423. 17:32action there are quite a few minor
  424. 17:35mechanisms of action
  425. 17:37but we're just going to present the most
  426. 17:39important ones here. If you're shooting
  427. 17:41for a distinction or high distinction
  428. 17:42once again you'll have to supplement
  429. 17:44your answer with some well researched
  430. 17:47facts and also you'll have to reference
  431. 17:50those appropriately.
  432. 17:55And once again I have another hint for
  433. 17:57you. Make sure that you discuss the
  434. 17:58appropriate measures that will decrease
  435. 18:01the likelihood of the most important
  436. 18:04adverse effect.
  437. 18:07And just a further note on that hint
  438. 18:11metformin can rarely cause a thing
  439. 18:14called lactic acidosis. Um
  440. 18:17the the the biguanides were actually
  441. 18:20taken off the market because they
  442. 18:21severely they they caused lactic
  443. 18:24acidosis in a large percentage of
  444. 18:26people. But Metformin is still on the
  445. 18:28market
  446. 18:29and there is a rare chance of it causing
  447. 18:32lactic acidosis. That's a
  448. 18:33life-threatening disorder
  449. 18:35and of course
  450. 18:37once again you don't just list
  451. 18:40that as being a side effect.
  452. 18:43What are you going to do with that
  453. 18:44information? You know how are you going
  454. 18:46to make sure that that doesn't happen?
  455. 18:48In this instance it's really important
  456. 18:51that you take a look at the
  457. 18:55uh individual's liver function test
  458. 18:57because liver function test will give
  459. 18:59you a a bit of an idea of whether
  460. 19:01there's malfunction in the liver
  461. 19:04and make sure that they do have a good
  462. 19:06functioning liver and also make sure
  463. 19:08that they don't binge drink. So if you
  464. 19:10make sure of both of those things then
  465. 19:13there's almost no chance of Metformin
  466. 19:16causing lactic acidosis.
  467. 19:18So just in general I just want to make
  468. 19:20sure that you you don't just say
  469. 19:22Metformin can cause lactic acidosis. It
  470. 19:25would be more of a thing like
  471. 19:28because Metformin can cause lactic
  472. 19:31acidosis a liver function test
  473. 19:35should be performed and and you should
  474. 19:38make sure that they don't binge drink
  475. 19:40while taking the drug or something to
  476. 19:42that effect, okay? So not just
  477. 19:46it causes lactic acidosis.
  478. 19:49Okay, I'll discuss all of that in just a
  479. 19:52little bit but I just wanted to flag
  480. 19:55that in this little introduction to the
  481. 20:00uh the the question.
  482. 20:02Only specific biguanide that's available
  483. 20:05in Australia, New Zealand, and UK is
  484. 20:07Metformin.
  485. 20:09Metformin is a
  486. 20:11first-line therapy for diabetes
  487. 20:13mellitus. It's an oral hypoglycemic
  488. 20:17agent. Just a little history on that
  489. 20:20previous biguanides that were available
  490. 20:23included buformin and phenformin, but
  491. 20:26both of those were withdrawn from the
  492. 20:28market because they did have a very high
  493. 20:31risk of developing lactic acidosis.
  494. 20:35Metformin can cause lactic acidosis, but
  495. 20:38it's a very rare thing. And if we do our
  496. 20:41homework prior to
  497. 20:43having it prescribed, then the there's
  498. 20:46pretty much no chance of the person
  499. 20:47having lactic acidosis. So it's really
  500. 20:49important to do your homework with the
  501. 20:51individual client. First of all, let's
  502. 20:54back up and ask the question, you know,
  503. 20:55what is lactic acidosis?
  504. 20:58Lactic acidosis is a condition where
  505. 21:00there's an excess amount of lactate
  506. 21:03built up in the system.
  507. 21:05I made a simple flowchart so that you
  508. 21:07can see exactly what normally happens.
  509. 21:09So normally glucose
  510. 21:11is going to enter the cells. And we say
  511. 21:13that glucose is our energy supply, but
  512. 21:15the thing is that it's actually broken
  513. 21:17up into two pieces, two three-carbon
  514. 21:20moieties instead of one carbon one six
  515. 21:23carbon sugar. So so we break it up into
  516. 21:27two pyruvates
  517. 21:29and then the pyruvate is going to be our
  518. 21:31energy currency. And we get a lot of
  519. 21:33energy from the pyruvate. But there's
  520. 21:36always a little bit of this pyruvate
  521. 21:38that's not actually turned into energy
  522. 21:40straight away or there's not enough
  523. 21:42oxygen in the cell to turn it into
  524. 21:44energy. And what happens at that point
  525. 21:47is that the pyruvate turns into lactate,
  526. 21:50which is a bit acidic.
  527. 21:53The lactate is then kind of shipped
  528. 21:54around over to the liver and then the
  529. 21:57liver changes the lactate back to
  530. 22:00glucose. And then we can just use it
  531. 22:02with no problems.
  532. 22:04Well, this is where the buformins come
  533. 22:07unstuck because of the fact that one of
  534. 22:09the mechanisms of action of metformin is
  535. 22:12that it decreases the hepatic production
  536. 22:15of glucose.
  537. 22:17And one of the very ways that it does
  538. 22:19that is that it affects the liver's
  539. 22:21ability to change lactate back into
  540. 22:24glucose.
  541. 22:26With a good functioning liver, it's
  542. 22:29still no problem, but uh if the person
  543. 22:32does have liver disease or if they binge
  544. 22:35drink, that person could wind up with
  545. 22:37lactic acidosis, which is that increased
  546. 22:41systemic amount of uh lactate uh of the
  547. 22:44acidic lactate.
  548. 22:46And I did say, you know, if the person
  549. 22:48binge drinks, you know, what what does
  550. 22:49binge drinking have to do with it? Well,
  551. 22:52anytime a person binge drinks, they're
  552. 22:53basically
  553. 22:55giving themselves a temporary liver
  554. 22:57malfunction because the liver says, wow,
  555. 23:00uh I'm going to have to deal with this
  556. 23:02straight away. So the so so the liver
  557. 23:04actually metabolizes the alcohol
  558. 23:06straight away, puts everything else on
  559. 23:07hold, and basically you can kind of
  560. 23:10regard the liver being a bit of a
  561. 23:12malfunctioning state at that point.
  562. 23:16So before a person is prescribed
  563. 23:18metformin, the client should be checked
  564. 23:20to make sure that they number one don't
  565. 23:22have any liver problems, number two they
  566. 23:24don't binge drink, and number three that
  567. 23:27they have a good functioning set of
  568. 23:29kidneys. So the kidneys are are really
  569. 23:32important in this lactate as well.
  570. 23:35The uh liver function test gives you the
  571. 23:38information about the liver. So as the
  572. 23:40enzymes are high, it means that there's
  573. 23:43damage in the liver and you need to look
  574. 23:45into it.
  575. 23:46Uh
  576. 23:47the the blood urea nitrogen and also the
  577. 23:50creatinine
  578. 23:52is the thing that gives you the
  579. 23:54information about the function of the
  580. 23:56kidneys, and you'll just need to make
  581. 23:59sure to ask the person how much alcohol
  582. 24:01they consume as well.
  583. 24:03The other mechanism by which metformin
  584. 24:06works is this one right here by
  585. 24:08increasing the insulin sensitivity. So
  586. 24:11metformin actually increases the binding
  587. 24:14of insulin to the receptor, makes it
  588. 24:16stick there longer, and therefore we
  589. 24:18have more glucose port transport carrier
  590. 24:21molecules. So you remember all the
  591. 24:23things that I was saying about
  592. 24:25hyperinsulinemia
  593. 24:28and the things that hyperinsulinemia can
  594. 24:31cause, well,
  595. 24:33would you think that this drug would
  596. 24:35actually be good for the people who have
  597. 24:38obesity and polycystic ovarian syndrome?
  598. 24:41It is. Yes. So this is the this is where
  599. 24:44you would actually choose Okay, you've
  600. 24:46got two patients over here. Uh one
  601. 24:48patient is uh moderately obese. She's 24
  602. 24:52years of age. Uh she's had a little bit
  603. 24:54of problems menstruating and and that
  604. 24:56kind of thing. And well, you choose
  605. 24:59metformin for this person. You you don't
  606. 25:01choose the sulfonylureas for this person
  607. 25:05because the fact that um you know, the
  608. 25:07metformin actually has a a potential of
  609. 25:10normalizing some of that
  610. 25:12uh cascade of events that's occurring in
  611. 25:15her polycystic ovarian syndrome.
  612. 25:18Whereas the sulfonylureas are going to
  613. 25:20do the exact opposite. They're actually
  614. 25:22going to make that worse. Conversely, if
  615. 25:24you had another patient who is has been
  616. 25:27a diabetic for a really long period of
  617. 25:29time, often times their problem is that
  618. 25:31they're actually decreasing the amount
  619. 25:34of insulin in their production. They
  620. 25:37can't make enough insulin normally.
  621. 25:40Their stimulus for making that insulin
  622. 25:43isn't enough. And that's where your
  623. 25:45sulfonylureas would come in.
  624. 25:47So that is a really important
  625. 25:51mechanism of action, this one for
  626. 25:52metformin, and that's the reason that
  627. 25:54metformin is the number one therapy for
  628. 25:57diabetics.
  629. 25:58And then you may mention that there is
  630. 26:01also a decrease absorption of glucose
  631. 26:04from the gastrointestinal tract. So this
  632. 26:07is a representation of a uh microvilli
  633. 26:12and the glucose coming into the body.
  634. 26:15We do have a little bit of a decrease
  635. 26:17absorption of that which just adds a
  636. 26:19little bit extra support with metformin.
  637. 26:22I guess the other time that you might
  638. 26:24use the sulfonylureas
  639. 26:27would be
  640. 26:28with perhaps like let metformin when
  641. 26:31they're really really have a super high
  642. 26:34level of glucose and they're really
  643. 26:37damaging their neurons, they're really
  644. 26:39damaging their retina of the eye, their
  645. 26:41glomerulus with this high level of
  646. 26:44glucose because the higher level of
  647. 26:46glucose we get the worse it is for all
  648. 26:49of those delicate structures in the
  649. 26:51body. So there's a few applications for
  650. 26:54the sulfonylureas, but it's definitely
  651. 26:56not in that patient who has potentially
  652. 27:00polycystic ovarian syndrome developing.
  653. 27:03This just gets to a couple questions and
  654. 27:05how does it affect the weight? And
  655. 27:08metformin doesn't really have any effect
  656. 27:10on the weight in type 2 diabetes
  657. 27:12patients, but if anything it's actually
  658. 27:15going to decrease the weight.
  659. 27:17And so when you do when you take a
  660. 27:20double-blind placebo-controlled trial of
  661. 27:22a cohort of individuals and you're
  662. 27:23saying does it do this or this, there's
  663. 27:25certain individuals who will respond
  664. 27:28well and actually get some benefit and
  665. 27:30actually get some weight reduction, but
  666. 27:33as you average everything out their
  667. 27:36weight is not affected. Metformin has
  668. 27:38been used off-label though as a weight
  669. 27:41loss agent. So
  670. 27:43if the person doesn't have diabetes or
  671. 27:45has prediabetes sometimes they give it
  672. 27:48kind of like as an off-label medication
  673. 27:51for decreasing the weight and
  674. 27:53normalizing things.
  675. 27:56Other things can it cause hypoglycemia?
  676. 27:58I would say it almost never happens
  677. 28:01and nobody in medicine really says never
  678. 28:05never ever ever never happens because
  679. 28:07there's always an exception to the rule.
  680. 28:09You know you you really don't have to
  681. 28:11worry about hypoglycemia with metformin
  682. 28:13if it's a monotherapy. Obviously if
  683. 28:16you're combining it with the
  684. 28:18sulfonylureas
  685. 28:19then that's the point at which you need
  686. 28:21to think about the possibility of
  687. 28:23hypoglycemia forming.
  688. 28:25And it's also been used to prevent
  689. 28:28diabetes as well. So just at that stage
  690. 28:31of insulin insensitivity to try to get
  691. 28:34the muscles cells to become sensitive to
  692. 28:38the insulin. If you get them to become
  693. 28:40sensitive to the insulin, then you
  694. 28:44often times delay the onset of actual
  695. 28:46diabetes.
  696. 28:48But the other thing is that how does
  697. 28:50this compare to diet and exercise? Diet
  698. 28:52and exercise therapy is actually more
  699. 28:55efficacious. So if you do have the
  700. 28:58opportunity to work with the patient
  701. 29:00with the diet and exercise therapy and
  702. 29:02there's a lot of diet and exercise
  703. 29:03therapies that would be beneficial for
  704. 29:06this patient, but
  705. 29:08but
  706. 29:09biguanides are only about half as
  707. 29:11effective as the diet and and as a
  708. 29:13really good diet and exercise therapy.
  709. 29:17This is just flow chart of the
  710. 29:20relationship between weight and
  711. 29:22polycystic ovarian syndrome and just
  712. 29:25placing some of the things in this flow
  713. 29:29chart. So the obesity occurs in like you
  714. 29:32never know where does it happen. It's
  715. 29:34kind of like the chicken or the egg kind
  716. 29:36of scenario where it's a a vicious cycle
  717. 29:40and somebody gets insulin resistance.
  718. 29:42That might be the first thing and then
  719. 29:44the insulin resistance actually does
  720. 29:46contribute to the obesity as we were
  721. 29:48saying before because it actually
  722. 29:50increases levels of insulin and the
  723. 29:52increased levels of insulin increase
  724. 29:54obesity. So the obesity then goes and
  725. 29:57and increases the insulin resistance and
  726. 30:01then hyperinsulinemia and and and that
  727. 30:04starts changing the production of
  728. 30:06hormones at the level of the ovaries
  729. 30:08winds up with polycystic ovarian
  730. 30:09syndrome and this and the thing goes
  731. 30:11around and around in circles.
  732. 30:13So where does metformin work? Well, we
  733. 30:16have a decrease in insulin resistance.
  734. 30:19So we have this this is the
  735. 30:21one of the main portions of the cycle
  736. 30:24that metformin is going to work. But
  737. 30:27like I said with all chronic disorders,
  738. 30:29you don't want to just do one thing. If
  739. 30:31you can get something else in there, if
  740. 30:33you can actually, you know, get them to
  741. 30:35decrease their weight as well as as
  742. 30:38giving them a
  743. 31:44symptoms will be alleviated or decreased
  744. 31:48quite substantially.

About this transcript

This page contains the full transcript of tutorial on diabetes part 3 t5 by PharmacoPhoto, generated from the public captions YouTube serves with the video. The transcript has 4,469 words across 744 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.

What you can do with it

Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to choose a caption track available on the video.

Free YouTube transcript tool

YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, caption language selection, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.